These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9590118)

  • 1. Over-expression of epidermal growth factor receptor and c-erbB2/neu but not of int-2 genes in benign prostatic hyperplasia by means of semi-quantitative PCR.
    Schwartz S; Caceres C; Morote J; De Torres I; Rodriguez-Vallejo JM; Gonzalez J; Reventos J
    Int J Cancer; 1998 May; 76(4):464-7. PubMed ID: 9590118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction.
    Esteller M; García A; Martínez i Palones JM; Cabero A; Reventós J
    Cancer; 1995 Apr; 75(8):2139-46. PubMed ID: 7697605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen-independent basal cell re-epithelialization, c-erbB-2 mRNA expression and androgen-dependent EGFr mRNA expression in benign prostatic hyperplasia explant cultures treated with finasteride.
    Schwartz S; Caceres C; De Torres I; Morote J; Rodriguez-Vallejo JM; Gonzalez J; Reventos J
    Int J Cancer; 1998 May; 76(4):519-22. PubMed ID: 9590128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [int-2 and c-erbB-2 gene amplification in urological cancers].
    Sato K; Kato T; Moriyama M
    Nihon Hinyokika Gakkai Zasshi; 1992 Dec; 83(12):1957-63. PubMed ID: 1361954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of epidermal growth factor receptor mRNA levels in normal, benign hyperplastic and carcinomatous prostate.
    Kumar VL; Majumder PK; Gujral S; Kumar V
    Cancer Lett; 1998 Dec; 134(2):177-80. PubMed ID: 10025878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples.
    Hruza C; Dobianer K; Beck A; Czerwenka K; Hanak H; Klein M; Leodolter S; Medl M; Müllauer-Ertl S; Preiser J
    Eur J Cancer; 1993; 29A(11):1593-7. PubMed ID: 8105839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. int-2 and c-erbB-2 gene amplification detected in 70 frozen human breast carcinomas by quantitative polymerase chain reaction.
    An HX; Niederacher D; Dominik SI; Kuschel B; Yan H; Dall P; Schnürch HG; Bender HG; Beckmann MW
    Anticancer Res; 1997; 17(4B):3133-6. PubMed ID: 9329619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and cellular localization of keratinocyte growth factor and its receptor in human hyperplastic prostate tissue.
    De Bellis A; Crescioli C; Grappone C; Milani S; Ghiandi P; Forti G; Serio M
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2186-91. PubMed ID: 9626158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor receptor 1 (FGFR1) is over-expressed in benign prostatic hyperplasia whereas FGFR2-IIIc and FGFR3 are not.
    Boget S; Cereser C; Parvaz P; Leriche A; Revol A
    Eur J Endocrinol; 2001 Sep; 145(3):303-10. PubMed ID: 11517011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study.
    Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP
    Prostate; 1993; 23(4):329-36. PubMed ID: 7505056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between epidermal growth factor and its receptor in human benign prostatic hyperplasia.
    Lubrano C; Toscano V; Petrangeli E; Spera G; Trotta MC; Rombolà N; Frati L; Di Silverio F; Sciarra F
    J Steroid Biochem Mol Biol; 1993 Oct; 46(4):463-8. PubMed ID: 7692939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice.
    Kitsberg DI; Leder P
    Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The significance of c-erbB-2 and int-2 gene alterations and DNA ploidy pattern for aggressiveness of breast cancer].
    Nagayama K; Watatani M; Maeda S; Imanishi Y; Kurooka K; Wada T; Yasutomi M
    Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1144-52. PubMed ID: 7901748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.
    Janbabai G; Oladi Z; Farazmandfar T; Taghvaei T; Naghshvar F
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1945-52. PubMed ID: 25820598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Int-2/FGF3 amplification is a better independent predictor of relapse than c-myc and c-erbB-2/neu amplifications in primary human breast cancer.
    Champème MH; Bièche I; Hacène K; Lidereau R
    Mod Pathol; 1994 Dec; 7(9):900-5. PubMed ID: 7892157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.